1
|
Miao P, Terris-Prestholt F, Fairley CK, Tucker JD, Wiseman V, Mayaud P, Zhang Y, Rowley J, Gottlieb S, Korenromp EL, Watts CG, Ong JJ. Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection. Health Qual Life Outcomes 2024; 22:17. [PMID: 38350925 PMCID: PMC10863090 DOI: 10.1186/s12955-024-02234-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Accepted: 01/29/2024] [Indexed: 02/15/2024] Open
Abstract
BACKGROUND Syphilis is a sexually transmitted infection causing significant global morbidity and mortality. To inform policymaking and economic evaluation studies for syphilis, we summarised utility and disability weights for health states associated with syphilis. METHODS We conducted a systematic review, searching six databases for economic evaluations and primary valuation studies related to syphilis from January 2000 to February 2022. We extracted health state utility values or disability weights, including identification of how these were derived. The study was registered in the international prospective register of systematic reviews (PROSPERO, CRD42021230035). FINDINGS Of 3401 studies screened, 22 economic evaluations, two primary studies providing condition-specific measures, and 13 burden of disease studies were included. Fifteen economic evaluations reported outcomes as disability-adjusted life years (DALYs) and seven reported quality-adjusted life years (QALYs). Fourteen of 15 economic evaluations that used DALYS based their values on the original Global Burden of Disease (GBD) study from 1990 (published in 1996). For the seven QALY-related economic evaluations, the methodology varied between studies, with some studies using assumptions and others creating utility weights or converting them from disability weights. INTERPRETATION We found a limited evidence base for the valuation of health states for syphilis, a lack of transparency for the development of existing health state utility values, and inconsistencies in the application of these values to estimate DALYs and QALYs. Further research is required to expand the evidence base so that policymakers can access accurate and well-informed economic evaluations to allocate resources to address syphilis and implement syphilis programs that are cost-effective.
Collapse
Affiliation(s)
- Patrick Miao
- Central Clinical School, Monash University, Melbourne, Australia
- Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Victoria, 3053, Australia
| | - Fern Terris-Prestholt
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
- UNAIDS, Geneva, Switzerland
| | - Christopher K Fairley
- Central Clinical School, Monash University, Melbourne, Australia
- Melbourne Sexual Health Centre, Melbourne, Australia
| | - Joseph D Tucker
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
- University of North Carolina at Chapel Hill, Chapel Hill, USA
| | - Virginia Wiseman
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Kirby Institute, University of New South Wales, Sydney, Australia
| | - Philippe Mayaud
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - Ying Zhang
- Central Clinical School, Monash University, Melbourne, Australia
| | - Jane Rowley
- Global HIV, Hepatitis and Sexual Transmitted Infections Programme, World Health Organization, Geneva, Switzerland
| | - Sami Gottlieb
- Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | | | - Caroline G Watts
- Kirby Institute, University of New South Wales, Sydney, Australia
- The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia
| | - Jason J Ong
- Central Clinical School, Monash University, Melbourne, Australia.
- Melbourne Sexual Health Centre, Melbourne, Australia.
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
| |
Collapse
|
2
|
Bruni L, Albero G, Rowley J, Taylor M, Broutet N. Randomised recruitment in estimating genital human papillomavirus prevalence - Authors' reply. Lancet Glob Health 2024; 12:e31. [PMID: 38097292 DOI: 10.1016/s2214-109x(23)00552-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Accepted: 11/21/2023] [Indexed: 12/18/2023]
Affiliation(s)
- Laia Bruni
- Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain.
| | - Ginesa Albero
- Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain
| | - Jane Rowley
- Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland
| | - Melanie Taylor
- Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Nathalie Broutet
- Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| |
Collapse
|
3
|
Gaspar PC, Rowley J, Pascom ARP, Korenromp E, Pascual F, Pereira GFM, Miranda AE. Gonorrhea prevalence in adults in Brazil: Spectrum-STI trend estimation, 2000-2020. Rev Soc Bras Med Trop 2023; 56:e02032023. [PMID: 38018565 DOI: 10.1590/0037-8682-0203-2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 10/18/2023] [Indexed: 11/30/2023] Open
Abstract
BACKGROUND Gonorrhea is not a notifiable disease in Brazil, and the national health information system does not collect data on reported cases or infection prevalence. METHODS We compiled published data on gonorrhea prevalence in Brazil from cross-sectional surveys and clinical trials between 2000 and 2020. The study entry criteria included a sample size of 50 or more, and Neisseria gonorrhoeae infection detected in urine, urethral, anal, or cervicovaginal specimens using either Nucleic Acid Amplification Test or culture. Gonorrhea prevalence trends between 2000 and 2020 were generated using Spectrum-STI, a statistical trend-fitting model. RESULTS Forty-five studies with 59 gonorrhea prevalence data points were identified. Fifty data points were for women and represented 21,815 individuals, eight for men encompassing a total of 4,587 individuals, and one for transgender people comprising 345 individuals. The Spectrum-STI estimate for the prevalence of urogenital infection with gonorrhea in women 15-49 in 2020 was 0.63% (95% confidence interval (CI): 0.13-2.23) and was lower than the 1.05% estimated value for 2000 (95% CI: 0.36-2.79). The corresponding figures for men were 0.70% (95% CI: 0.16-2.44) and 1.14% (95% CI: 0.34-3.15). Anal prevalence estimates could not be generated because of insufficient data (three data points). CONCLUSIONS These results suggest that the overall prevalence of genitourinary gonococcal infections in Brazil is less than 1%. Data on gonorrhea prevalence in men and in populations at increased STI vulnerability are limited.
Collapse
Affiliation(s)
- Pâmela Cristina Gaspar
- Ministério da Saúde, Departamento de HIV/aids, tuberculose, hepatites virais e infecções sexualmente transmissíveis, Brasília, Distrito Federal, Brasil
- Universidade de Brasília, Programa de Pós-Graduação em Saúde Coletiva, Brasília, Distrito Federal, Brasil
| | - Jane Rowley
- World Health Organization, Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, Geneva, Switzerland
| | - Ana Roberta Pati Pascom
- Ministério da Saúde, Departamento de HIV/aids, tuberculose, hepatites virais e infecções sexualmente transmissíveis, Brasília, Distrito Federal, Brasil
| | - Eline Korenromp
- Avenir Health, Geneva, Switzerland
- United Nations Programme on HIV/AIDS, Data for Impact Department, Geneva, Switzerland
| | | | - Gerson Fernando Mendes Pereira
- Ministério da Saúde, Departamento de HIV/aids, tuberculose, hepatites virais e infecções sexualmente transmissíveis, Brasília, Distrito Federal, Brasil
| | - Angelica Espinosa Miranda
- Ministério da Saúde, Departamento de HIV/aids, tuberculose, hepatites virais e infecções sexualmente transmissíveis, Brasília, Distrito Federal, Brasil
- Universidade Federal do Espírito Santo, Programa de Pós-Graduação em Doenças Infecciosas, Vitória, Espírito Santo, Brasil
| |
Collapse
|
4
|
Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, Markowitz LE, Broutet N, Taylor M. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health 2023; 11:e1345-e1362. [PMID: 37591583 PMCID: PMC10447222 DOI: 10.1016/s2214-109x(23)00305-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 05/26/2023] [Accepted: 06/20/2023] [Indexed: 08/19/2023]
Abstract
BACKGROUND The epidemiology of human papillomavirus (HPV) in women has been well documented. Less is known about the epidemiology of HPV in men. We aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men. METHODS We conducted a systematic review and meta-analysis to assess the prevalence of genital HPV infection in the general male population. We searched Embase, Ovid MEDLINE, and the Global Index Medicus for studies published between Jan 1, 1995, and June 1, 2022. Inclusion criteria were population-based surveys in men aged 15 years or older or HPV prevalence studies with a sample size of at least 50 men with no HPV-related pathology or known risk factors for HPV infection that collected samples from anogenital sites and used PCR or hybrid capture 2 techniques for HPV DNA detection. Exclusion criteria were studies conducted among populations at increased risk of HPV infection, exclusively conducted among circumcised men, and based on urine or semen samples. We screened identified reports and extracted summary-level data from those that were eligible. Data were extracted by two researchers independently and reviewed by a third, and discrepancies were resolved by consensus. We extracted only data on mucosal α-genus HPVs. Global and regional age-specific prevalences for any HPV, high-risk (HR)-HPV, and individual HPV types were estimated using random-effects models for meta-analysis and grouped by UN Sustainable Development Goals geographical classification. FINDINGS We identified 5685 publications from database searches, of which 65 studies (comprising 44 769 men) were included from 35 countries. The global pooled prevalence was 31% (95% CI 27-35) for any HPV and 21% (18-24) for HR-HPV. HPV-16 was the most prevalent HPV genotype (5%, 95% CI 4-7) followed by HPV-6 (4%, 3-5). HPV prevalence was high in young adults, reaching a maximum between the ages of 25 years and 29 years, and stabilised or slightly decreased thereafter. Pooled prevalence estimates were similar for the UN Sustainable Development Goal geographical regions of Europe and Northern America, Sub-Saharan Africa, Latin America and the Caribbean, and Australia and New Zealand (Oceania). The estimates for Eastern and South-Eastern Asia were half that of the other regions. INTERPRETATION Almost one in three men worldwide are infected with at least one genital HPV type and around one in five men are infected with one or more HR-HPV types. Our findings show that HPV prevalence is high in men over the age of 15 years and support that sexually active men, regardless of age, are an important reservoir of HPV genital infection. These estimates emphasise the importance of incorporating men in comprehensive HPV prevention strategies to reduce HPV-related morbidity and mortality in men and ultimately achieve elimination of cervical cancer and other HPV-related diseases. FUNDING Instituto de Salud Carlos III, European Regional Development Fund, Secretariat for Universities and Research of the Department of Business and Knowledge of the Government of Catalonia, and Horizon 2020. TRANSLATIONS For the Spanish and French translations of the abstract see Supplementary Materials section.
Collapse
Affiliation(s)
- Laia Bruni
- Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain.
| | - Ginesa Albero
- Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain
| | - Jane Rowley
- Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland
| | - Laia Alemany
- Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP CB06/02/0073), Madrid, Spain
| | - Marc Arbyn
- Unit of Cancer Epidemiology-Belgian Cancer Centre, Sciensano, Belgium
| | - Anna R Giuliano
- Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA
| | - Lauri E Markowitz
- Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Nathalie Broutet
- Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | - Melanie Taylor
- Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
| |
Collapse
|
5
|
Towns JM, Tieosapjaroen W, Mello MB, Baggaley RC, Johnson CC, Jamil MS, Rowley J, Barr-DiChiara M, Terris-Prestholt F, Chen MY, Chow EPF, Fairley CK, Zhang L, Ong JJ. The role of syphilis self-testing as an additional syphilis testing approach in key populations: a systematic review and meta-analysis. Lancet Public Health 2023; 8:e726-e734. [PMID: 37482070 DOI: 10.1016/s2468-2667(23)00128-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 06/16/2023] [Accepted: 06/19/2023] [Indexed: 07/25/2023]
Abstract
BACKGROUND Syphilis is causing epidemics in many countries. Syphilis self-testing (SST) has potential to increase testing and treatment coverage in the same manner as documented for self-testing of, for example, HIV, hepatitis C virus, and COVID-19. We aimed to synthesise current evidence on the utility of SST. METHODS We conducted a systematic review and, where possible, meta-analysis. We searched MEDLINE, Embase, CINAHL, Scopus, and Web of Science for publications published from Jan 1, 2000, to Oct 13, 2022. We included publications with original data on any syphilis rapid tests, including dual HIV-syphilis tests. Study populations were not restricted. We used random-effects meta-analysis to calculate the pooled proportion of people offered SST who undertook the test. The systematic review was registered in PROSPERO (CRD42022302129). FINDINGS In total, 40 499 citations were identified. 11 publications from seven studies from the USA, Zimbabwe, and China met eligibility criteria. Of those, four studies reported data from men who have sex with men and five studies used dual HIV-SST. Using data from one randomised controlled trial and three observational studies, the pooled proportion of people who received SST kits who undertook the test was 88% (95% CI 85-91). No studies provided data on the sensitivity or specificity of SST. Overall, user and provider preference for SST was high, with participants reporting convenience, privacy, rapid results, autonomy, trust in blood-based tests, decreased facility contact, and time savings, with individuals being able to correctly self-test. Publications from China reported that SST had lower costs per person tested than existing facility-based testing options. INTERPRETATION Our review builds on the literature for self-testing across different disease areas and demonstrates that SST has the potential to reach underserved populations. As this review found that SST use was acceptable and feasible to implement, SST can be used as an additional syphilis testing approach. Since no data on the sensitivity and specificity of SST were found, further implementation research will be required to guide the best strategies for SST service delivery and future scale-up. FUNDING WHO, Australian National Health and Medical Research Council, and Unitaid.
Collapse
Affiliation(s)
- Janet M Towns
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia
| | - Warittha Tieosapjaroen
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia
| | - Maeve B Mello
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland
| | - Rachel C Baggaley
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland
| | - Cheryl C Johnson
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland
| | - Muhammad S Jamil
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland
| | - Jane Rowley
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland
| | | | | | - Marcus Y Chen
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia
| | - Eric P F Chow
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Christopher K Fairley
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia
| | - Lei Zhang
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia
| | - Jason J Ong
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
| |
Collapse
|
6
|
Peters RPH, Chico RM, Rowley J, Low N. Estimating the global burden of sexually transmitted infections. Lancet Infect Dis 2022; 22:1112-1113. [PMID: 35870456 DOI: 10.1016/s1473-3099(22)00415-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 05/31/2022] [Indexed: 06/15/2023]
Affiliation(s)
- Remco P H Peters
- Research Unit, Foundation for Professional Development, East London 5217, South Africa; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
| | - R Matthew Chico
- Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK
| | - Jane Rowley
- Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland
| | - Nicola Low
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
| |
Collapse
|
7
|
Heath K, Alonso M, Aguilar G, Samudio T, Korenromp E, Rowley J, Suleiman A, Shwe YY, Htin KCW, Ishikawa N, Newman Owiredu M, Taylor M. WHO method for estimating congenital syphilis to inform surveillance and service provision, Paraguay. Bull World Health Organ 2022; 100:231-236. [PMID: 35261411 PMCID: PMC8886258 DOI: 10.2471/blt.20.271569] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 12/10/2021] [Accepted: 12/10/2021] [Indexed: 11/27/2022] Open
Abstract
Problem In Paraguay, incomplete surveillance data resulted in the burden of congenital syphilis being underestimated, which, in turn, led to missed opportunities for infant diagnosis and treatment. Approach The prevalence of congenital syphilis, as defined by the World Health Organization (WHO), was estimated for Paraguay using the WHO congenital syphilis estimation tool. This tool was also used to monitor progress towards the elimination of mother-to-child transmission of syphilis. Local setting The burden of syphilis in Paraguay has historically been high: its prevalence in pregnant women was estimated to be 3% in 2018. Relevant changes The incidence rate of congenital syphilis estimated using the WHO tool was around nine times the reported prevalence. Subsequently, Paraguay: (i) provided training to improve diagnosis and case reporting; (ii) strengthened information systems for case monitoring and reporting; and (iii) procured additional rapid dual HIV–syphilis and rapid plasma reagin tests to increase syphilis testing capacity. In addition, the Ministry of Health prepared a new national plan for eliminating mother-to-child transmission of syphilis, with clear monitoring milestones. Lessons learnt Health-care providers’ reporting and surveillance procedures for congenital syphilis may not adequately reflect national and international case definitions. Use of the WHO congenital syphilis estimation tool in Paraguay drew attention to congenital syphilis as a national public health problem and highlighted the importance of comprehensive national surveillance systems and accurate data. Ongoing use of the WHO tool can track progress towards the elimination of mother-to-child transmission of syphilis by helping improve syphilis service coverage and national surveillance.
Collapse
|
8
|
Diehl S, Kim A, Angelini G, Joo K, Adhikari S, Amaryan M, Arratia M, Atac H, Avakian H, Ayerbe Gayoso C, Baltzell NA, Barion L, Bastami S, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Brooks W, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chetry T, Ciullo G, Clark L, Clary BA, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Dilks C, Djalali C, Dugger M, Dupre R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Forest T, Gavalian G, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hafidi K, Hakobyan H, Hattawy M, Hauenstein F, Hayward TB, Heddle D, Hicks K, Hobart A, Holtrop M, Hyde CE, Ireland DG, Isupov EL, Jo HS, Johnston R, Joosten S, Keller D, Khachatryan M, Khanal A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lee S, Lenisa P, Livingston K, Lu Z, MacGregor IJD, Marchand D, Markov N, Marsicano L, Mascagna V, McKinnon B, Meziani ZE, Milner RG, Mineeva T, Mirazita M, Mokeev V, Moran P, Movsisyan A, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Nanda S, Neupane K, Niccolai S, Niculescu G, O'Connell TR, Osipenko M, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pogorelko O, Prok Y, Prokudin A, Raue BA, Ripani M, Ritman J, Rizzo A, Roberts CD, Rossi P, Rowley J, Sabatié F, Salgado C, Schmidt A, Segarra EP, Sharabian YG, Shrestha U, Simmerling P, Sokhan D, Soto O, Sparveris N, Stepanyan S, Stoler P, Strakovsky II, Strauch S, Tezgin K, Thornton A, Tyler N, Tyson R, Ungaro M, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei K, Wei X, Xu SS, Yale B, Zachariou N, Zhang J. Multidimensional, High Precision Measurements of Beam Single Spin Asymmetries in Semi-inclusive π^{+} Electroproduction off Protons in the Valence Region. Phys Rev Lett 2022; 128:062005. [PMID: 35213183 DOI: 10.1103/physrevlett.128.062005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2021] [Revised: 09/28/2021] [Accepted: 01/21/2022] [Indexed: 06/14/2023]
Abstract
High precision measurements of the polarized electron beam-spin asymmetry in semi-inclusive deep inelastic scattering (SIDIS) from the proton have been performed using a 10.6 GeV incident electron beam and the CLAS12 spectrometer at Jefferson Lab. We report here a high precision multidimensional study of single π^{+} SIDIS data over a large kinematic range in Bjorken x, fractional energy, and transverse momentum of the hadron as well as photon virtualities Q^{2} ranging from 1-7 GeV^{2}. In particular, the structure function ratio F_{LU}^{sinϕ}/F_{UU} has been determined, where F_{LU}^{sinϕ} is a twist-3 quantity that can reveal novel aspects of emergent hadron mass and quark-gluon correlations within the nucleon. The data's impact on the evolving understanding of the underlying reaction mechanisms and their kinematic variation is explored using theoretical models for the different contributing transverse momentum dependent parton distribution functions.
Collapse
Affiliation(s)
- S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - G Angelini
- The George Washington University, Washington, D.C. 20052, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - S Adhikari
- Florida International University, Miami, Florida 33199, USA
| | - M Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Arratia
- University of California, Riverside, California 92521, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - S Bastami
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-T Brinkmann
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- Universitá di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - B A Clary
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P L Cole
- Lamar University, 4400 MLK Blvd, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - M Dugger
- Arizona State University, Tempe, Arizona 85281, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - T Forest
- Idaho State University, Pocatello, Idaho 83209, USA
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - F Hauenstein
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- Universitá di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z Lu
- School of Physics, Southeast University, Nanjing 211189, Jiangsu, China
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - N Markov
- University of Connecticut, Storrs, Connecticut 06269, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Moran
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - A Movsisyan
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Nanda
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Universitá di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Prokudin
- Science Division, Penn State University Berks, Reading, Pennsylvania 19610, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- Institute fur Kernphysik (Juelich), Juelich, Germany
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome Italy
| | - C D Roberts
- School of Physics and Institute for Nonperturbative Physics, Nanjing University, Nanjing 210093, Jiangsu, China
| | - P Rossi
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - E P Segarra
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Stoler
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Tezgin
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Thornton
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S-S Xu
- School of Science, Nanjing University of Posts and Telecommunications, Nanjing 210023, Jiangsu, China
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| |
Collapse
|
9
|
Rowley J, Compton N, Djalali C, Hicks K, Price J, Zachariou N, Adhikari KP, Armstrong WR, Atac H, Baashen L, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dupré R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fradi A, Gavalian G, Girod FX, Glazier DI, Golubenko A, Gothe RW, Griffioen K, Guo L, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jenkins D, Jo HS, Joo K, Keller D, Khanal A, Khandaker M, Kim A, Korover I, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Markov N, Marsicano L, Mascagna V, McCracken ME, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Munevar E, Munoz Camacho C, Nadel-Turonski P, Neupane K, Niccolai S, Niculescu G, O'Connell TR, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Pasyuk E, Pogorelko O, Prok Y, Reed T, Ripani M, Ritman J, Rizzo A, Rosner G, Sabatie F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shrestha U, Sokhan D, Soto O, Sparveris N, Strakovsky II, Strauch S, Tyson R, Ungaro M, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei K, Wei X, Wishart R, Wood MH, Yale B, Yurov M, Zhang J, Zhao ZW. Improved Λp Elastic Scattering Cross Sections between 0.9 and 2.0 GeV/c as a Main Ingredient of the Neutron Star Equation of State. Phys Rev Lett 2021; 127:272303. [PMID: 35061432 DOI: 10.1103/physrevlett.127.272303] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 08/18/2021] [Accepted: 12/07/2021] [Indexed: 06/14/2023]
Abstract
Strange matter is believed to exist in the cores of neutron stars based on simple kinematics. If this is true, then hyperon-nucleon interactions will play a significant part in the neutron star equation of state. Yet, compared to other elastic scattering processes, there is very little data on Λ-N scattering. This experiment utilized the CEBAF Large Acceptance Spectrometer (CLAS) detector to study the Λp→Λp elastic scattering cross section in the incident Λ momentum range 0.9-2.0 GeV/c. These are the first data on this reaction since the 1970s. The new cross sections have significantly better accuracy and precision than the existing world data, and the techniques developed here can also be used in future experiments.
Collapse
Affiliation(s)
- J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - N Compton
- Ohio University, Athens, Ohio 45701, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - J Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - K P Adhikari
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Catania, 95123 Catania, Italy
- INFN, Sezione di Genova, 16146 Genova, Italy
- Universià degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupré
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - G Fedotov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - R Fersch
- Christopher Newport University, Newport News, Virginia 23606, USA
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - A Fradi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Gavalian
- Old Dominion University, Norfolk, Virginia 23529, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F X Girod
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Keller
- Ohio University, Athens, Ohio 45701, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - I Korover
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - N Markov
- University of Connecticut, Storrs, Connecticut 06269, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - M E McCracken
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - T Mineeva
- University of Connecticut, Storrs, Connecticut 06269, USA
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Munevar
- The George Washington University, Washington, D.C. 20052, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Catholic University of America, Washington, D.C. 20064, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- Institute fur Kernphysik (Juelich), 52425 Juelich, Germany
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatie
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- University of Connecticut, Storrs, Connecticut 06269, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Yurov
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - J Zhang
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| |
Collapse
|
10
|
Chatagnon P, Niccolai S, Stepanyan S, Amaryan MJ, Angelini G, Armstrong WR, Atac H, Ayerbe Gayoso C, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Caudron M, Celentano A, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, Defurne M, De Vita R, Deur A, Diehl S, Djalali C, Dupré R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Fersch R, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Guo L, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Joo K, Kabir ML, Keller D, Khachatryan G, Khanal A, Kim A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lee S, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Marsicano L, Mascagna V, McKinnon B, McLauchlin C, Migliorati S, Mirazita M, Mokeev V, Montgomery RA, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Neupane K, O'Connell TR, Osipenko M, Ouillon M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pogorelko O, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Ripani M, Rizzo A, Rossi P, Rowley J, Sabatié F, Schmidt A, Segarra EP, Sharabian YG, Shirokov EV, Shrestha U, Sokhan D, Soto O, Sparveris N, Strakovsky II, Strauch S, Tyler N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei K, Wei X, Wishart R, Yale B, Zachariou N, Zhang J, Zhao ZW. First Measurement of Timelike Compton Scattering. Phys Rev Lett 2021; 127:262501. [PMID: 35029502 DOI: 10.1103/physrevlett.127.262501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Revised: 10/21/2021] [Accepted: 11/11/2021] [Indexed: 06/14/2023]
Abstract
We present the first measurement of the timelike Compton scattering process, γp→p^{'}γ^{*}(γ^{*}→e^{+}e^{-}), obtained with the CLAS12 detector at Jefferson Lab. The photon beam polarization and the decay lepton angular asymmetries are reported in the range of timelike photon virtualities 2.25<Q^{'2}<9 GeV^{2}, squared momentum transferred 0.1<-t<0.8 GeV^{2}, and average total center-of-mass energy squared s=14.5 GeV^{2}. The photon beam polarization asymmetry, similar to the beam-spin asymmetry in deep virtual Compton scattering, is sensitive to the imaginary part of the Compton form factors and provides a way to test the universality of the generalized parton distributions. The angular asymmetry of the decay leptons accesses the real part of the Compton form factors and thus the D-term in the parametrization of the generalized parton distributions.
Collapse
Affiliation(s)
- P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G Angelini
- The George Washington University, Washington, D.C. 20052, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Universit'a degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - M Caudron
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P L Cole
- Lamar University, 4400 M. L. King, Jr. Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - R Dupré
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - R Fersch
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | | | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Ouillon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - E P Segarra
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| |
Collapse
|
11
|
Chico RM, Tsuboi M, Evans J, Davies EP, Rowley J, Korenromp EL, Clayton T, Mabey D, Taylor MM. Estimating burden of syphilis among men who have sex with men – Authors' reply. The Lancet Global Health 2021; 9:e1649. [PMID: 34798018 PMCID: PMC9128567 DOI: 10.1016/s2214-109x(21)00449-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Accepted: 09/23/2021] [Indexed: 11/24/2022] Open
|
12
|
Rowley J, Richards N, Carduff E, Gott M. The impact of poverty and deprivation at the end of life: a critical review. Palliat Care Soc Pract 2021; 15:26323524211033873. [PMID: 34541536 PMCID: PMC8442481 DOI: 10.1177/26323524211033873] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 07/01/2021] [Indexed: 11/22/2022] Open
Abstract
This critical review interrogates what we know about how poverty and deprivation impact people at the end of life and what more we need to uncover. While we know that people in economically resource-rich countries who experience poverty and deprivation over the life course are likely to die younger, with increased co-morbidities, palliative care researchers are beginning to establish a full picture of the disproportionate impact of poverty on how, when and where we die. This is something the Covid-19 pandemic has further illustrated. Our article uses a critical social science lens to investigate an eclectic range of literature addressing health inequities and is focused on poverty and deprivation at the end of life. Our aim was to see if we could shed new light on the myriad ways in which experiences of poverty shape the end of people's lives. We start by exploring the definitions and language of poverty while acknowledging the multiple intersecting identities that produce privilege. We then discuss poverty and deprivation as a context for the nature of palliative care need and overall end-of-life circumstances. In particular, we explore: total pain; choice at the end of life; access to palliative care; and family caregiving. Overall, we argue that in addressing the effects of poverty and deprivation on end-of-life experiences, there is a need to recognise not just socio-economic injustice but also cultural and symbolic injustice. Too often, a deficit-based approach is adopted which both 'Others' those living with poverty and renders invisible the strategies and resilience they develop to support themselves, their families and communities. We conclude with some recommendations for future research, highlighting in particular the need to amplify the voices of people with lived experience of poverty regarding palliative and end-of-life care.
Collapse
Affiliation(s)
- Jane Rowley
- End of Life Studies Group, School of
Interdisciplinary Studies, University of Glasgow, Glasgow, UK
| | - Naomi Richards
- End of Life Studies Group, School of
Interdisciplinary Studies, University of Glasgow, Glasgow, UK
| | | | - Merryn Gott
- Professor, Te Ārai Palliative Care and End of
Life Research Group, School of Nursing, The University of Auckland, Private
Bag 92019, Auckland 1142, New Zealand
| |
Collapse
|
13
|
Tsuboi M, Evans J, Davies EP, Rowley J, Korenromp EL, Clayton T, Taylor MM, Mabey D, Chico RM. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20. Lancet Glob Health 2021; 9:e1110-e1118. [PMID: 34246332 PMCID: PMC9150735 DOI: 10.1016/s2214-109x(21)00221-7] [Citation(s) in RCA: 80] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2020] [Revised: 04/11/2021] [Accepted: 04/26/2021] [Indexed: 01/20/2023]
Abstract
BACKGROUND The WHO Global Health Sector Strategy aims to reduce worldwide syphilis incidence by 90% between 2018 and 2030. If this goal is to be achieved, interventions that target high-burden groups, including men who have sex with men (MSM), will be required. However, there are no global prevalence estimates of syphilis among MSM to serve as a baseline for monitoring or modelling disease burden. We aimed to assess the global prevalence of syphilis among MSM using the available literature. METHODS In this global systematic review and meta-analysis, we searched MEDLINE, Embase, LILACS, and AIM databases, and Integrated Bio-Behavioral Surveillance (IBBS) reports between April 23, 2019, and Feb 1, 2020, to identify studies done between Jan 1, 2000, and Feb 1, 2020, with syphilis point prevalence data measured by biological assay among MSM (defined as people who were assigned as male at birth and had oral or anal sex with at least one other man in their lifetime). Studies were excluded if participants were exclusively HIV-infected MSM, injection-drug users, only seeking care for sexually transmitted infections (STIs) or genital symptoms, or routine STI clinic attendees. Data were extracted onto standardised forms and cross-checked for accuracy and validity. We used random-effects models to generate pooled prevalence estimates across the eight regions of the Sustainable Development Goals. We calculated risk of study bias based on the Appraisal tool for Cross-Sectional Studies, and stratified results based on low versus high risk of bias. This systematic review and meta-analysis was registered with PROSPERO, CRD42019144594. FINDINGS We reviewed 4339 records, 228 IBBS reports, and ten articles from other sources. Of these, 1301 duplicate records were excluded, 2467 records were excluded after title and abstract screening, and 534 articles were excluded after full-text analysis. We identified 345 prevalence data points from 275 studies across 77 countries, with a total of 606 232 participants. Global pooled prevalence from 2000-20 was 7·5% (95% CI 7·0-8·0%), ranging from 1·9% (1·0-3·1%) in Australia and New Zealand to 10·6% (8·5-12·9%) in Latin America and the Caribbean. INTERPRETATION Unacceptably high syphilis prevalence among MSM warrants urgent action. FUNDING Wellcome Trust.
Collapse
Affiliation(s)
- Motoyuki Tsuboi
- Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
| | - Jayne Evans
- Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
| | - Ella P Davies
- Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
| | | | | | - Tim Clayton
- Department of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK
| | - Melanie M Taylor
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland; Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, GA, USA
| | - David Mabey
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
| | - R Matthew Chico
- Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
| |
Collapse
|
14
|
Hayward TB, Dilks C, Vossen A, Avakian H, Adhikari S, Angelini G, Arratia M, Atac H, Ayerbe Gayoso C, Baltzell NA, Barion L, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bondì M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chetry T, Ciullo G, Clary BA, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Djalali C, Dupre R, Dugger M, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Forest TA, Gavalian G, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hafidi K, Hakobyan H, Hattawy M, Hauenstein F, Hicks K, Hobart A, Holtrop M, Ireland DG, Isupov EL, Jo HS, Joo K, Joosten S, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lee S, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Markov N, Marsicano L, Mascagna V, McKinnon B, Meziani ZE, Mirazita M, Mokeev V, Movsisyan A, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Nanda S, Neupane K, Niccolai S, Niculescu G, O'Connell TR, Osipenko M, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pogorelko O, Prok Y, Raue BA, Ripani M, Ritman J, Rizzo A, Rossi P, Rowley J, Sabatié F, Salgado C, Schmidt A, Segarra EP, Sharabian YG, Shrestha U, Sokhan D, Soto O, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Thornton A, Tyler N, Tyson R, Ungaro M, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei K, Wei X, Wood MH, Yale B, Zachariou N, Zhang J. Observation of Beam Spin Asymmetries in the Process ep→e^{'}π^{+}π^{-}X with CLAS12. Phys Rev Lett 2021; 126:152501. [PMID: 33929247 DOI: 10.1103/physrevlett.126.152501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Revised: 02/25/2021] [Accepted: 03/18/2021] [Indexed: 06/12/2023]
Abstract
The observation of beam spin asymmetries in two-pion production in semi-inclusive deep inelastic scattering off an unpolarized proton target is reported. The data presented here were taken in the fall of 2018 with the CLAS12 spectrometer using a 10.6 GeV longitudinally spin-polarized electron beam delivered by CEBAF at JLab. The measured asymmetries provide the first opportunity to extract the parton distribution function e(x), which provides information about the interaction between gluons and quarks, in a collinear framework that offers cleaner access than previous measurements. The asymmetries also constitute the first ever signal sensitive to the helicity-dependent two-pion fragmentation function G_{1}^{⊥}. A clear sign change is observed around the ρ mass that appears in model calculations and is indicative of the dependence of the produced pions on the helicity of the fragmenting quark.
Collapse
Affiliation(s)
- T B Hayward
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Adhikari
- Florida International University, Miami, Florida 33199, USA
| | - G Angelini
- The George Washington University, Washington, D.C. 20052, USA
| | - M Arratia
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of California, Riverside, Riverside, California 92521, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Battaglieri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondì
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - B A Clary
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Dugger
- Arizona State University, Tempe, Arizona 85287, USA
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - T A Forest
- Idaho State University, Pocatello, Idaho 83209, USA
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - F Hauenstein
- Old Dominion University, Norfolk, Virginia 23529, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - N Markov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Movsisyan
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Nanda
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B A Raue
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- Institute fur Kernphysik (Juelich), Juelich 52428, Germany
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - E P Segarra
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Thornton
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Venturelli
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M H Wood
- Canisius College, Buffalo, New York 14208-1098, USA
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| |
Collapse
|
15
|
Machekera S, Boas P, Temu P, Mosende Z, Lote N, Kelly-Hanku A, Mahiane SG, Glaubius R, Rowley J, Gurung A, Korenromp E. Strategic options for syphilis control in Papua New Guinea- impact and cost-effectiveness projections using the syphilis interventions towards elimination (SITE) model. Infect Dis Model 2021; 6:584-597. [PMID: 33869906 PMCID: PMC8039768 DOI: 10.1016/j.idm.2021.03.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 03/08/2021] [Accepted: 03/09/2021] [Indexed: 11/19/2022] Open
Abstract
Objectives Papua New Guinea (PNG) has among the highest rates of sexually transmitted infections (STIs) globally and is committed to reducing their incidence. The Syphilis Interventions Towards Elimination (SITE) model was used to explore the expected impact and cost of alternative syphilis intervention scale-up scenarios. Methods SITE is a dynamical model of syphilis transmission among adults 15-49 years. Individuals are divided into nine groups based on sexual behaviour and into six stages of infection. The model was calibrated to PNG using data from routine surveillance, bio-behavioural surveys, research studies and program records. Inputs included syphilis prevalence, risk behaviours, intervention coverage and service delivery unit costs. Scenarios compared different interventions (clinical treatment, contact tracing, syphilis screening, and condom promotion) for incidence and cost per infection averted over 2021-2030. Results Increasing treatment coverage of symptomatic primary/secondary-stage syphilis cases from 25-35% in 2020 to 60% from 2023 onwards reduced estimated incidence over 2021-2030 by 55%, compared to a scenario assuming constant coverage at 2019-2020 levels. The introduction of contact tracing in 2020, assuming 0.4 contacts per symptomatic person treated, reduced incidence over 2021-2030 by 10%. Increasing screening coverage by 20-30 percentage points from the 2019-2020 level reduced incidence over 2021-2030 by 3-16% depending on the target population. Scaling-up clinical, symptom-driven treatment and contact tracing had the lowest cost per infection averted, followed by condom promotion and periodic screening of female sex workers and men who have sex with men. Conclusions PNG could considerably reduce its syphilis burden by scaling-up clinical treatment and contact tracing alongside targeted behavioural risk reduction interventions. SITE is a useful tool countries can apply to inform national STI programming and resource allocation.
Collapse
Key Words
- (I)BBS, (Integrated) Bio-Behavioural Survey
- ANC, antenatal care
- Cost-effectiveness
- DHS, Demographic and Health Survey
- FSW, Female Sex Worker
- GUD, Genital Ulcer Disease
- MSM, Men who have sex with men
- National program strategy
- PNG, Papua New Guinea
- PoM, Port Moresby
- Prevention
- RPR, Rapid Plasma Reagin test
- Resource allocation
- STI, sexually transmitted infection
- Syphilis
- TPHA, Treponema pallidum hemagglutination assay
- TPPA, Treponema pallidum particle agglutination assay
- Treatment
- VDRL, Venereal Disease Research Laboratory
- WHO, World Health Organization
Collapse
Affiliation(s)
- Shepherd Machekera
- Government of Papua New Guinea, National Department of Health, AOPI Center, Waigani Drive, PO Box, 5896, Port Moresby, Papua New Guinea
- World Vision International, Ruta Place, Morata St, Gordons. P.O Box 4254, Boroko, National Capital District, Port Moresby, Papua New Guinea
| | - Peniel Boas
- Government of Papua New Guinea, National Department of Health, AOPI Center, Waigani Drive, PO Box, 5896, Port Moresby, Papua New Guinea
| | - Poruan Temu
- Government of Papua New Guinea, National Department of Health, AOPI Center, Waigani Drive, PO Box, 5896, Port Moresby, Papua New Guinea
| | | | - Namarola Lote
- Government of Papua New Guinea, National Department of Health, AOPI Center, Waigani Drive, PO Box, 5896, Port Moresby, Papua New Guinea
- WHO Papua New Guinea Country Office, Communicable Disease & Health Emergency Dept., AOPI Centre, Waigani Drive, Port Moresby, Papua New Guinea
| | - Angela Kelly-Hanku
- Papua New Guinea Institute of Medical Research, 441 Homate Street, PO Box 60, Goroka, Eastern Highland Province, Papua New Guinea
- Kirby Institute, UNSW Sydney, Wallace Wurth Building, High Street, UNSW Australia Kensington, NSW 2052, Sydney, Australia
| | - S. Guy Mahiane
- Avenir Health, Modelling, Planning and Policy Analysis Dept., 655 Winding Brook Drive, Glastonbury, CT, 06033, USA
| | - Robert Glaubius
- Avenir Health, Modelling, Planning and Policy Analysis Dept., 655 Winding Brook Drive, Glastonbury, CT, 06033, USA
| | - Jane Rowley
- Independent Consultant, 135 Gloucester Terrace, W2 6DX, London, UK
| | - Anup Gurung
- WHO Papua New Guinea Country Office, Communicable Disease & Health Emergency Dept., AOPI Centre, Waigani Drive, Port Moresby, Papua New Guinea
| | - Eline Korenromp
- Avenir Health, Modelling, Planning and Policy Analysis Dept., 150 Route de Ferney, PO box 2100, CH-1211 Geneva 2, Switzerland
- Corresponding author.
| |
Collapse
|
16
|
Carver M, Celentano A, Hicks K, Marsicano L, Mathieu V, Pilloni A, Adhikari KP, Adhikari S, Amaryan MJ, Angelini G, Atac H, Baltzell NA, Barion L, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Chatagnon P, Chetry T, Ciullo G, Clark L, Clary BA, Cole PL, Contalbrigo M, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Djalali C, Dugger M, Dupre R, Egiyan H, Ehrhart M, Alaoui AE, Fassi LE, Eugenio P, Fedotov G, Fegan S, Filippi A, Gavalian G, Gevorgyan N, Gilfoyle GP, Girod FX, Gothe RW, Griffioen KA, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Holtrop M, Huang Q, Hyde CE, Ilieva Y, Ireland DG, Isupov EL, Jenkins D, Jo HS, Joo K, Joosten S, Keller D, Khanal A, Khandaker M, Kim A, Kim CW, Klein FJ, Kripko A, Kubarovsky V, Lanza L, Leali M, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Mascagna V, McCracken ME, McKinnon B, Meziani ZE, Mokeev V, Movsisyan A, Munevar E, Camacho CM, Nadel-Turonski P, Neupane K, Niccolai S, Niculescu G, Osipenko M, Ostrovidov AI, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pogorelko O, Prok Y, Protopopescu D, Ripani M, Ritchie BG, Ritman J, Rizzo A, Rosner G, Rowley J, Sabatié F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shrestha U, Sokhan D, Soto O, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tyler N, Tyson R, Ungaro M, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei K, Wei X, Yale B, Zachariou N, Zhang J, Zhao ZW. Photoproduction of the f_{2}(1270) Meson Using the CLAS Detector. Phys Rev Lett 2021; 126:082002. [PMID: 33709753 DOI: 10.1103/physrevlett.126.082002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 01/08/2021] [Accepted: 02/04/2021] [Indexed: 06/12/2023]
Abstract
The quark structure of the f_{2}(1270) meson has, for many years, been assumed to be a pure quark-antiquark (qq[over ¯]) resonance with quantum numbers J^{PC}=2^{++}. Recently, it was proposed that the f_{2}(1270) is a molecular state made from the attractive interaction of two ρ mesons. Such a state would be expected to decay strongly to final states with charged pions due to the dominant decay ρ→π^{+}π^{-}, whereas decay to two neutral pions would likely be suppressed. Here, we measure for the first time the reaction γp→π^{0}π^{0}p, using the CEBAF Large Acceptance Spectrometer detector at Jefferson Lab for incident beam energies between 3.6 and 5.4 GeV. Differential cross sections, dσ/dt, for f_{2}(1270) photoproduction are extracted with good precision due to low backgrounds and are compared to theoretical calculations.
Collapse
Affiliation(s)
- M Carver
- Ohio University, Athens, Ohio 45701, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mathieu
- Departamento de Fsica Terica and IPARCOS, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - A Pilloni
- INFN, Sezione di Genova, 16146 Genova, Italy
- European Centre for Theoretical Studies in Nuclear Physics and Related Areas (ECT*) and Fondazione Bruno Kessler, Strada delle Tavarnelle 286, Villazzano (Trento) I-38123, Italy
- INFN, Sezione di Roma, 00185 Roma, Italy
| | - K P Adhikari
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - S Adhikari
- Florida International University, Miami, Florida 33199, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G Angelini
- The George Washington University, Washington, D.C. 20052, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - P Chatagnon
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - B A Clary
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, PO Box 10046, Beaumont, Texas 77710, USA
- Idaho State University, Pocatello, Idaho 83209, USA
| | | | - V Crede
- Florida State University, Tallahassee, Florida 32306 USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen 35392, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Dugger
- Arizona State University, Tempe, Arizona 85287-1504, USA
| | - R Dupre
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - M Ehrhart
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306 USA
| | - G Fedotov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- Old Dominion University, Norfolk, Virginia 23529, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - N Gevorgyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - D Heddle
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Q Huang
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- Ohio University, Athens, Ohio 45701, USA
- University of Virginia, Charlottesville, Virginia 22901j, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C W Kim
- The George Washington University, Washington, D.C. 20052, USA
| | - F J Klein
- Catholic University of America, Washington, D.C. 20064, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen 35392, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - M E McCracken
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - A Movsisyan
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - E Munevar
- The George Washington University, Washington, D.C. 20052, USA
| | - C Munoz Camacho
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Catholic University of America, Washington, D.C. 20064, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306 USA
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901j, USA
| | | | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - B G Ritchie
- Arizona State University, Tempe, Arizona 85287-1504, USA
| | - J Ritman
- Institute fur Kernphysik (Juelich), Juelich, Germany
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - L Venturelli
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901j, USA
| | - Z W Zhao
- University of South Carolina, Columbia, South Carolina 29208, USA
- Duke University, Durham, North Carolina 27708-0305, USA
| |
Collapse
|
17
|
Diehl S, Joo K, Kim A, Avakian H, Kroll P, Park K, Riser D, Semenov-Tian-Shansky K, Tezgin K, Adhikari KP, Adhikari S, Amaryan MJ, Angelini G, Asryan G, Atac H, Barion L, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Dilks C, Djalali C, Dupre R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Eugenio P, Filippi A, Forest TA, Ghandilyan Y, Gilfoyle GP, Giovanetti KL, Girod FX, Glazier DI, Golovatch E, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Harrison N, Hattawy M, Hayward TB, Heddle D, Hicks K, Holtrop M, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jenkins D, Jo HS, Joosten S, Keller D, Khachatryan M, Khanal A, Khandaker M, Kim CW, Kim W, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Markov N, Marsicano L, Mascagna V, McKinnon B, Meziani ZE, Mineeva T, Mirazita M, Mokeev V, Munoz Camacho C, Nadel-Turonski P, Niculescu G, Osipenko M, Paolone M, Pappalardo LL, Pasyuk E, Phelps W, Pogorelko O, Price JW, Prok Y, Raue BA, Ripani M, Rizzo A, Rossi P, Rowley J, Sabatié F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shrestha U, Soto O, Sparveris N, Stepanyan S, Stoler P, Strakovsky II, Strauch S, Tan JA, Tyler N, Ungaro M, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei X, Wood MH, Zachariou N, Zhang J, Zhao ZW. Extraction of Beam-Spin Asymmetries from the Hard Exclusive π^{+} Channel off Protons in a Wide Range of Kinematics. Phys Rev Lett 2020; 125:182001. [PMID: 33196236 DOI: 10.1103/physrevlett.125.182001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Revised: 06/08/2020] [Accepted: 07/30/2020] [Indexed: 06/11/2023]
Abstract
We have measured beam-spin asymmetries to extract the sinϕ moment A_{LU}^{sinϕ} from the hard exclusive e[over →]p→e^{'}nπ^{+} reaction above the resonance region, for the first time with nearly full coverage from forward to backward angles in the center of mass. The A_{LU}^{sinϕ} moment has been measured up to 6.6 GeV^{2} in -t, covering the kinematic regimes of generalized parton distributions (GPD) and baryon-to-meson transition distribution amplitudes (TDA) at the same time. The experimental results in very forward kinematics demonstrate the sensitivity to chiral-odd and chiral-even GPDs. In very backward kinematics where the TDA framework is applicable, we found A_{LU}^{sinϕ} to be negative, while a sign change was observed near 90° in the center of mass. The unique results presented in this Letter will provide critical constraints to establish reaction mechanisms that can help to further develop the GPD and TDA frameworks.
Collapse
Affiliation(s)
- S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- Justus Liebig University Giessen, 35392 Giessen, Germany
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Kroll
- Fachbereich Physik, Universitat Wuppertal, D-42097 Wuppertal, Germany
| | - K Park
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - D Riser
- University of Connecticut, Storrs, Connecticut 06269, USA
| | | | - K Tezgin
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - K P Adhikari
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - S Adhikari
- Florida International University, Miami, Florida 33199, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G Angelini
- The George Washington University, Washington, District of Columbia 20052, USA
| | - G Asryan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, District of Columbia 20052, USA
| | - W K Brooks
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - G Ciullo
- Universita' di Ferrara , 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P L Cole
- Lamar University, Beaumont, Texas 77705, USA
| | | | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - T A Forest
- Idaho State University, Pocatello, Idaho 83209
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - K L Giovanetti
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E Golovatch
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - N Harrison
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- The George Washington University, Washington, District of Columbia 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - B S Ishkhanov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- National Research Centre Kurchatov Institute, Petersburg Nuclear Physics Institute, RU-188300 Gatchina, Russia
| | - C W Kim
- The George Washington University, Washington, District of Columbia 20052, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - V Kubarovsky
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - N Markov
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Munoz Camacho
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Universita' di Ferrara , 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome Italy
| | - P Rossi
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, District of Columbia 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Stoler
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
| | - I I Strakovsky
- The George Washington University, Washington, District of Columbia 20052, USA
| | - S Strauch
- The George Washington University, Washington, District of Columbia 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Ungaro
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| |
Collapse
|
18
|
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N, Taylor MM. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019; 97:548-562P. [PMID: 31384073 PMCID: PMC6653813 DOI: 10.2471/blt.18.228486] [Citation(s) in RCA: 822] [Impact Index Per Article: 164.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Revised: 04/08/2019] [Accepted: 05/03/2019] [Indexed: 12/22/2022] Open
Abstract
OBJECTIVE To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15-49 years, in 2016. METHODS For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. FINDINGS For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3-4.5); gonorrhoea 0.9% (95% UI: 0.7-1.1); trichomoniasis 5.3% (95% UI:4.0-7.2); and syphilis 0.5% (95% UI: 0.4-0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9-3.7); gonorrhoea 0.7% (95% UI: 0.5-1.1); trichomoniasis 0.6% (95% UI: 0.4-0.9); and syphilis 0.5% (95% UI: 0.4-0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1-165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6-123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4-231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5-7.1 million) syphilis cases. CONCLUSION Global estimates of prevalence and incidence of these four curable sexually transmitted infections remain high. The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016-2021.
Collapse
Affiliation(s)
- Jane Rowley
- Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Stephen Vander Hoorn
- School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia
| | | | - Nicola Low
- Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
| | - Magnus Unemo
- WHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden
| | - Laith J Abu-Raddad
- Department of Healthcare Policy and Research, Weill Cornell Medical College - Qatar, Doha, Qatar
| | - R Matthew Chico
- Department of Disease Control, London School of Hygiene & Tropical Medicine, London, England
| | - Alex Smolak
- Department of Healthcare Policy and Research, Weill Cornell Medical College - Qatar, Doha, Qatar
| | - Lori Newman
- Enteric and Sexually Transmitted Infections Branch, National Institute of Allergy and Infectious Diseases, Washington DC, United States of America
| | - Sami Gottlieb
- Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Soe Soe Thwin
- Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Nathalie Broutet
- Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Melanie M Taylor
- Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
| |
Collapse
|
19
|
Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS, Mahiané SG, Ishikawa N, Le LV, Newman-Owiredu M, Nagelkerke N, Newman L, Kamb M, Broutet N, Taylor MM. Correction: Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One 2019; 14:e0219613. [PMID: 31276484 PMCID: PMC6611667 DOI: 10.1371/journal.pone.0219613] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
20
|
Korenromp EL, Rowley J, Alonso M, Mello MB, Wijesooriya NS, Mahiané SG, Ishikawa N, Le LV, Newman-Owiredu M, Nagelkerke N, Newman L, Kamb M, Broutet N, Taylor MM. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One 2019; 14:e0211720. [PMID: 30811406 PMCID: PMC6392238 DOI: 10.1371/journal.pone.0211720] [Citation(s) in RCA: 169] [Impact Index Per Article: 33.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Accepted: 10/26/2018] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND In 2007 the World Health Organization (WHO) launched the global initiative to eliminate mother-to-child transmission of syphilis (congenital syphilis, or CS). To assess progress towards the goal of <50 CS cases per 100,000 live births, we generated regional and global estimates of maternal and congenital syphilis for 2016 and updated the 2012 estimates. METHODS Maternal syphilis estimates were generated using the Spectrum-STI model, fitted to sentinel surveys and routine testing of pregnant women during antenatal care (ANC) and other representative population data. Global and regional estimates of CS used the same approach as previous WHO estimates. RESULTS The estimated global maternal syphilis prevalence in 2016 was 0.69% (95% confidence interval: 0.57-0.81%) resulting in a global CS rate of 473 (385-561) per 100,000 live births and 661,000 (538,000-784,000) total CS cases, including 355,000 (290,000-419,000) adverse birth outcomes (ABO) and 306,000 (249,000-363,000) non-clinical CS cases (infants without clinical signs born to un-treated mothers). The ABOs included 143,000 early fetal deaths and stillbirths, 61,000 neonatal deaths, 41,000 preterm or low-birth weight births, and 109,000 infants with clinical CS. Of these ABOs- 203,000 (57%) occurred in pregnant women attending ANC but not screened for syphilis; 74,000 (21%) in mothers not enrolled in ANC, 55,000 (16%) in mothers screened but not treated, and 23,000 (6%) in mothers enrolled, screened and treated. The revised 2012 estimates were 0.70% (95% CI: 0.63-0.77%) maternal prevalence, and 748,000 CS cases (539 per 100,000 live births) including 397,000 (361,000-432,000) ABOs. The estimated decrease in CS case rates between 2012 and 2016 reflected increased access to ANC and to syphilis screening and treatment. CONCLUSIONS Congenital syphilis decreased worldwide between 2012 and 2016, although maternal prevalence was stable. Achieving global CS elimination, however, will require improving access to early syphilis screening and treatment in ANC, clinically monitoring all women diagnosed with syphilis and their infants, improving partner management, and reducing syphilis prevalence in the general population by expanding testing, treatment and partner referral beyond ANC.
Collapse
Affiliation(s)
| | - Jane Rowley
- Independent consultant, London, United Kingdom
| | - Monica Alonso
- Department of Communicable Diseases and Environmental Determinants of Health, Pan-American Health Organization, Washington DC, United States of America
| | - Maeve B. Mello
- Department of Communicable Diseases and Environmental Determinants of Health, Pan-American Health Organization, Washington DC, United States of America
| | | | - S. Guy Mahiané
- Avenir Health, Glastonbury, Connecticut, United States of America
| | - Naoko Ishikawa
- World Health Organization, Regional Office for the Western Pacific, Manila, the Philippines
| | - Linh-Vi Le
- World Health Organization, Regional Office for the Western Pacific, Manila, the Philippines
| | - Morkor Newman-Owiredu
- World Health Organization, Sub-Saharan Africa Office, Brazzaville, Republic of Congo
| | | | - Lori Newman
- USA Centers for Disease Control and Prevention, Cambodia Country Office, Phnom Penh, Cambodia
| | - Mary Kamb
- USA Centers for Disease Control and Prevention, Cambodia Country Office, Phnom Penh, Cambodia
| | - Nathalie Broutet
- USA Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, Georgia, United States of America
| | - Melanie M. Taylor
- USA Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, Georgia, United States of America
- World Health Organization, Dept. of Reproductive Health and Research, Geneva, Switzerland
| |
Collapse
|
21
|
Kularatne RS, Niit R, Rowley J, Kufa-Chakezha T, Peters RPH, Taylor MM, Johnson LF, Korenromp EL. Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017. PLoS One 2018; 13:e0205863. [PMID: 30321236 PMCID: PMC6188893 DOI: 10.1371/journal.pone.0205863] [Citation(s) in RCA: 60] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Accepted: 10/02/2018] [Indexed: 11/25/2022] Open
Abstract
OBJECTIVES To estimate trends in prevalence and incidence of syphilis, gonorrhea and chlamydia in adult men and women in South Africa. METHODS The Spectrum-STI tool estimated trends in prevalence and incidence of active syphilis, gonorrhea and chlamydia, fitting South African prevalence data. Results were used, alongside programmatic surveillance data, to estimate trends in incident gonorrhea cases resistant to first-line treatment, and the reporting gap of symptomatic male gonorrhea and chlamydia cases treated but not reported as cases of urethritis syndrome. RESULTS In 2017 adult (15-49 years) the estimated female and male prevalences for syphilis were 0.50% (95% CI: 0.32-0.80%) and 0.97% (0.19-2.28%), for gonorrhea 6.6% (3.8-10.8%) and 3.5% (1.7-6.1%), and for chlamydia 14.7% (9.9-21%) and 6.0% (3.8-10.4%), respectively. Between 1990 and 2017 the estimated prevalence of syphilis declined steadily in women and men, probably in part reflecting improved treatment coverage. For gonorrhea and chlamydia, estimated prevalence and incidence showed no consistent time trend in either women or men. Despite growing annual numbers of gonorrhea cases - reflecting population growth - the estimated number of first line treatment-resistant gonorrhea cases did not increase between 2008 and 2017, owing to changes in first-line antimicrobial treatment regimens for gonorrhea in 2008 and 2014/5. Case reporting completeness among treated male urethritis syndrome episodes was estimated at 10-28% in 2017. CONCLUSION South Africa continues to suffer a high STI burden. Improvements in access and quality of maternal, STI and HIV health care services likely contributed to the decline in syphilis prevalence. The lack of any decline in gonorrhea and chlamydia prevalence highlights the need to enhance STI services beyond clinic-based syndromic case management, to reinvigorate primary STI and HIV prevention and, especially for women, to screen for asymptomatic infections.
Collapse
Affiliation(s)
- Ranmini S. Kularatne
- Centre for HIV & STI, National Institute for Communicable Diseases, Johannesburg, South Africa
- Department of Clinical Microbiology & Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Ronelle Niit
- Health Information Systems Programme, Pretoria, South Africa
| | - Jane Rowley
- Independent consultant, London, United Kingdom
| | - Tendesayi Kufa-Chakezha
- Centre for HIV & STI, National Institute for Communicable Diseases, Johannesburg, South Africa
| | - Remco P. H. Peters
- Anova Health Institute, Johannesburg, South Africa
- Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
| | - Melanie M. Taylor
- World Health Organization, Department of Reproductive Health and Research, Geneva, Switzerland
- USA Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, Georgia, United States of America
| | - Leigh F. Johnson
- University of Cape Town, Centre for Infectious Disease Epidemiology and Research, Cape Town, South Africa
| | | |
Collapse
|
22
|
Korenromp EL, Ríos C, Apolinar ALS, Caicedo S, Cuellar D, Cárdenas I, Nuñez RL, Cuéllar NC, Ruíz M, Cruz A, Gaitan-Duarte H, Valderrama CD, Forero MIB, Taylor M, Rowley J, Gómez B, Alonso M. Prevalence and incidence estimates for syphilis, chlamydia, gonorrhea, and congenital syphilis in Colombia, 1995-2016. Rev Panam Salud Publica 2018; 42:e118. [PMID: 31093146 PMCID: PMC6385794 DOI: 10.26633/rpsp.2018.118] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2017] [Accepted: 03/06/2018] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVES To estimate adult (15-49 years old) prevalence and incidence of active syphilis, gonorrhea, and chlamydia, and incidence of congenital syphilis (CS) and adverse birth outcomes (ABOs) in Colombia, over 1995-2016. METHODS The Spectrum-STI epidemiological model tool estimated gonorrhea and chlamydia prevalences as moving averages across prevalences observed in representative general population surveys. For adult syphilis, Spectrum-STI applied segmented polynomial regression through prevalence data from antenatal care (ANC) surveys, routine ANC-based screening, and general population surveys. CS cases and ABOs were estimated from Spectrum's maternal syphilis estimates and proportions of women screened and treated for syphilis, applying World Health Organization case definitions and risk probabilities. RESULTS The Spectrum model estimated prevalences in 2016 of 0.70% (95% confidence interval (CI): 0.15%-1.9%) in women and 0.60% (0.1%-1.9%) in men for gonorrhea and of 9.2% (4.4%-15.4%) in women and 7.4% (3.5%-14.7%) in men for chlamydia, without evidence for trends over 1995-2016. The prevalence of active syphilis in 2016 was 1.25% (1.22-1.29%) in women and 1.25% (1.1%-1.4%) in men, decreasing from 2.6% (2.1%-3.2%) in women in 1995. Corresponding CS cases in 2016 (including cases without clinical symptoms) totaled 3 851, of which 2 245 were ABOs. Annual CS and ABO estimates decreased over 2008-2016, reflecting decreasing maternal prevalence and increasing cases averted through ANC-based screening and treatment. CONCLUSIONS The available surveillance and monitoring data synthesized in Spectrum-STI- and the resulting first-ever national STI estimates for Colombia-highlighted Colombia's persistently high STI burden. Adult syphilis and congenital syphilis are estimated to be falling, reflecting improving screening efforts. Strengthened surveillance, including with periodic screening in low-risk populations and future refined Spectrum estimations, should support planning and implementation of STI prevention and control, including CS elimination.
Collapse
Affiliation(s)
| | - Cielo Ríos
- Ministry of Health and Social Protection, Bogotá, Bogotá, Colombia
| | | | - Sidia Caicedo
- Ministry of Health and Social Protection, Bogotá, Bogotá, Colombia
| | - Diego Cuellar
- Ministry of Health and Social Protection, Bogotá, Bogotá, Colombia
| | - Iván Cárdenas
- Ministry of Health and Social Protection, Bogotá, Bogotá, Colombia
| | | | | | - Martha Ruíz
- Ministry of Health and Social Protection, Bogotá, Bogotá, Colombia
| | - Adriana Cruz
- International Training Center and Medical Research, Cali, Colombia
| | | | | | | | - Melanie Taylor
- World Health Organization, Department of Reproductive Health and Research, Geneva, Switzerland
| | - Jane Rowley
- Independent consultant, London, London, United Kingdom
| | - Bertha Gómez
- Pan American Health Organization, Bogotá, Bogotá, Colombia
| | - Mónica Alonso
- Pan American Health Organization, Washington D.C., United States of America
| |
Collapse
|
23
|
Korenromp EL, Mahiané SG, Nagelkerke N, Taylor MM, Williams R, Chico RM, Pretorius C, Abu-Raddad LJ, Rowley J. Syphilis prevalence trends in adult women in 132 countries - estimations using the Spectrum Sexually Transmitted Infections model. Sci Rep 2018; 8:11503. [PMID: 30065272 PMCID: PMC6068092 DOI: 10.1038/s41598-018-29805-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2018] [Accepted: 07/17/2018] [Indexed: 11/09/2022] Open
Abstract
We estimated national-level trends in the prevalence of probable active syphilis in adult women using the Spectrum Sexually Transmitted Infections (STI) model to inform program planning, target-setting, and progress evaluation in STI control. The model fitted smoothed-splines polynomial regressions to data from antenatal clinic surveys and screening and representative household surveys, adjusted for diagnostic test performance and weighted by national coverage. Eligible countries had ≥1 data point from 2010 or later and ≥3 from 2000 or later from adult populations considered representative of the general female population (pregnant women or community-based studies). Between 2012 and 2016, the prevalence of probable active syphilis in women decreased in 54 (41%) of 132 eligible countries; this decrease was substantive (≥10% proportionally, ≥0.10% percentage-point absolute difference and non-overlapping 95% confidence intervals in 2012 and 2016) in 5 countries. Restricting eligible data to prevalence measurements of dual treponemal and non-treponemal testing limited estimates to 85 countries; of these, 45 countries (53%) showed a decrease. These standardized trend estimates highlight the need for increased investment in national syphilis surveillance and control efforts if the World Health Organization target of a 90% reduction in the incidence of syphilis between 2018 and 2030 is to be met.
Collapse
Affiliation(s)
| | | | | | - Melanie M Taylor
- World Health Organization, Dept. of Reproductive Health and Research, Geneva, Switzerland
- Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, Georgia, USA
| | - Rebecca Williams
- London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - R Matthew Chico
- London School of Hygiene and Tropical Medicine, London, United Kingdom
| | | | | | | |
Collapse
|
24
|
Smolak A, Rowley J, Nagelkerke N, Kassebaum NJ, Chico RM, Korenromp EL, Abu-Raddad LJ. Trends and Predictors of Syphilis Prevalence in the General Population: Global Pooled Analyses of 1103 Prevalence Measures Including 136 Million Syphilis Tests. Clin Infect Dis 2018; 66:1184-1191. [PMID: 29136161 PMCID: PMC5888928 DOI: 10.1093/cid/cix975] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2017] [Accepted: 11/06/2017] [Indexed: 12/31/2022] Open
Abstract
Background This study assessed levels, trends, and associations of observed syphilis prevalence in the general adult population using global pooled analyses. Methods A standardized database of syphilis prevalence was compiled by pooling systematically gathered data. Random-effects meta-analyses and meta-regressions were conducted using data from the period 1990-2016 to estimate pooled measures and assess predictors and trends. Countries were classified by World Health Organization region. Sensitivity analyses were conducted. Results The database included 1103 prevalence measures from 136 million syphilis tests across 154 countries (85% from women in antenatal care). Global pooled mean prevalence (weighted by region population size) was 1.11% (95% confidence interval [CI], .99-1.22). Prevalence predictors were region, diagnostic assay, sample size, and calendar year interacting with region. Compared to the African Region, the adjusted odds ratio (AOR) was 0.42 (95% CI, .33-.54) for the Region of the Americas, 0.13 (95% CI, .09-.19) for the Eastern Mediterranean Region, 0.05 (95% CI, .03-.07) for the European Region, 0.21 (95% CI, .16-.28) for the South-East Asia Region, and 0.41 (95% CI, .32-.53) for the Western Pacific Region. Treponema pallidum hemagglutination assay (TPHA) only or rapid plasma reagin (RPR) only, compared with dual RPR/TPHA diagnosis, produced higher prevalence (AOR >1.26), as did smaller sample-size studies (<500 persons) (AOR >2.16). Prevalence declined in all regions; the annual AORs ranged from 0.84 (95% CI, .79-.90) in the Eastern Mediterranean to 0.97 (95% CI, .97-1.01) in the Western Pacific. The pooled mean male-to-female prevalence ratio was 1.00 (95% CI, .89-1.13). Sensitivity analyses confirmed robustness of results. Conclusions Syphilis prevalence has declined globally over the past 3 decades. Large differences in prevalence persist among regions, with the African Region consistently the most affected.
Collapse
Affiliation(s)
- Alex Smolak
- Infectious Disease Epidemiology Group, Weill Cornell Medicine–Qatar, Cornell University, Doha, Qatar
| | | | | | - Nicholas J Kassebaum
- Institute for Health Metrics and Evaluation, University of Washington, Washington
- Division of Pediatric Anesthesiology, Seattle Children’s Hospital, Washington
| | - R Matthew Chico
- London School of Hygiene and Tropical Medicine, United Kingdom
| | | | - Laith J Abu-Raddad
- Infectious Disease Epidemiology Group, Weill Cornell Medicine–Qatar, Cornell University, Doha, Qatar
- Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, New York
| |
Collapse
|
25
|
Colletti LM, Copping R, Garduno K, Lujan EJW, Mauser AK, Mechler-Hickson A, May I, Reilly SD, Rios D, Rowley J, Schroeder AB. The application of visible absorption spectroscopy to the analysis of uranium in aqueous solutions. Talanta 2017; 175:390-405. [PMID: 28842008 DOI: 10.1016/j.talanta.2017.07.051] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2017] [Revised: 07/14/2017] [Accepted: 07/17/2017] [Indexed: 11/29/2022]
Abstract
Through assay analysis into an excess of 1M H2SO4 at fixed temperature a technique has been developed for uranium concentration analysis by visible absorption spectroscopy over an assay concentration range of 1.8-13.4mgU/g. Once implemented for a particular spectrophotometer and set of spectroscopic cells this technique promises to provide more rapid results than a classical method such as Davies-Gray (DG) titration analysis. While not as accurate and precise as the DG method, a comparative analysis study reveals that the spectroscopic method can analyze for uranium in well characterized uranyl(VI) solution samples to within 0.3% of the DG results. For unknown uranium solutions in which sample purity is less well defined agreement between the developed spectroscopic method and DG analysis is within 0.5%. The technique can also be used to detect the presence of impurities that impact the colorimetric analysis, as confirmed through the analysis of ruthenium contamination. Finally, extending the technique to other assay solution, 1M HNO3, HCl and Na2CO3, has also been shown to be viable. Of the four aqueous media the carbonate solution yields the largest molar absorptivity value at the most intensely absorbing band, with the least impact of temperature.
Collapse
Affiliation(s)
- L M Colletti
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - R Copping
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - K Garduno
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - E J W Lujan
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - A K Mauser
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA; The University of New Mexico, Albuquerque, NM 87131, USA
| | - A Mechler-Hickson
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA; The University of Wisconsin-Madison, Madison, WI 53715, USA
| | - I May
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA.
| | - S D Reilly
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA.
| | - D Rios
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - J Rowley
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA
| | - A B Schroeder
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87544, USA; The University of Wisconsin-Madison, Madison, WI 53715, USA
| |
Collapse
|
26
|
Rowley J, Hill BJ, Berman R, Sparrow A, Akinola M, VandeVusse A, Bak T, Gilliam M. Exploring the feasibility and acceptability of a high-school-based digital sexual assault prevention program: Bystander. Contraception 2017. [DOI: 10.1016/j.contraception.2017.07.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
27
|
Fatzinger McShane P, Geer J, Rowley J. State Dietetic Practice Group Gets Involved in State Regulation Revisions: Relevant, Vital and Never Dull. J Acad Nutr Diet 2017. [DOI: 10.1016/j.jand.2017.06.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
28
|
Bennani A, El-Kettani A, Hançali A, El-Rhilani H, Alami K, Youbi M, Rowley J, Abu-Raddad L, Smolak A, Taylor M, Mahiané G, Stover J, Korenromp EL. The prevalence and incidence of active syphilis in women in Morocco, 1995-2016: Model-based estimation and implications for STI surveillance. PLoS One 2017; 12:e0181498. [PMID: 28837558 PMCID: PMC5570350 DOI: 10.1371/journal.pone.0181498] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2017] [Accepted: 07/03/2017] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Evolving health priorities and resource constraints mean that countries require data on trends in sexually transmitted infections (STI) burden, to inform program planning and resource allocation. We applied the Spectrum STI estimation tool to estimate the prevalence and incidence of active syphilis in adult women in Morocco over 1995 to 2016. The results from the analysis are being used to inform Morocco's national HIV/STI strategy, target setting and program evaluation. METHODS Syphilis prevalence levels and trends were fitted through logistic regression to data from surveys in antenatal clinics, women attending family planning clinics and other general adult populations, as available post-1995. Prevalence data were adjusted for diagnostic test performance, and for the contribution of higher-risk populations not sampled in surveys. Incidence was inferred from prevalence by adjusting for the average duration of infection with active syphilis. RESULTS In 2016, active syphilis prevalence was estimated to be 0.56% in women 15 to 49 years of age (95% confidence interval, CI: 0.3%-1.0%), and around 21,675 (10,612-37,198) new syphilis infections have occurred. The analysis shows a steady decline in prevalence from 1995, when the prevalence was estimated to be 1.8% (1.0-3.5%). The decline was consistent with decreasing prevalences observed in TB patients, fishermen and prisoners followed over 2000-2012 through sentinel surveillance, and with a decline since 2003 in national HIV incidence estimated earlier through independent modelling. CONCLUSIONS Periodic population-based surveys allowed Morocco to estimate syphilis prevalence and incidence trends. This first-ever undertaking engaged and focused national stakeholders, and confirmed the still considerable syphilis burden. The latest survey was done in 2012 and so the trends are relatively uncertain after 2012. From 2017 Morocco plans to implement a system to record data from routine antenatal programmatic screening, which should help update and re-calibrate next trend estimations.
Collapse
Affiliation(s)
- Aziza Bennani
- Ministry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco
| | - Amina El-Kettani
- Ministry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco
| | - Amina Hançali
- STIs Laboratory, Department of Bacteriology, National Institute of Hygiene, Rabat, Morocco
| | | | - Kamal Alami
- UNAIDS Morocco country office, Rabat, Morocco
| | - Mohamed Youbi
- Ministry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco
| | | | - Laith Abu-Raddad
- Weill Cornell Medical College - Qatar, Cornell University, Doha, Qatar
| | - Alex Smolak
- Weill Cornell Medical College - Qatar, Cornell University, Doha, Qatar
| | - Melanie Taylor
- World Health Organization, Dept. of Reproductive Health and Research, Geneva, Switzerland
- Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, Georgia, United States of America
| | - Guy Mahiané
- Avenir Health, Glastonbury, Connecticut, United States of America
| | - John Stover
- Avenir Health, Glastonbury, Connecticut, United States of America
| | - Eline L. Korenromp
- Avenir Health, Glastonbury, Connecticut, United States of America
- * E-mail:
| |
Collapse
|
29
|
Korenromp EL, Mahiané G, Rowley J, Nagelkerke N, Abu-Raddad L, Ndowa F, El-Kettani A, El-Rhilani H, Mayaud P, Chico RM, Pretorius C, Hecht K, Wi T. Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016. Sex Transm Infect 2017; 93:599-606. [PMID: 28325771 PMCID: PMC5739862 DOI: 10.1136/sextrans-2016-052953] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Revised: 01/06/2017] [Accepted: 01/14/2017] [Indexed: 11/13/2022] Open
Abstract
Objective To develop a tool for estimating national trends in adult prevalence of sexually transmitted infections by low- and middle-income countries, using standardised, routinely collected programme indicator data. Methods The Spectrum-STI model fits time trends in the prevalence of active syphilis through logistic regression on prevalence data from antenatal clinic-based surveys, routine antenatal screening and general population surveys where available, weighting data by their national coverage and representativeness. Gonorrhoea prevalence was fitted as a moving average on population surveys (from the country, neighbouring countries and historic regional estimates), with trends informed additionally by urethral discharge case reports, where these were considered to have reasonably stable completeness. Prevalence data were adjusted for diagnostic test performance, high-risk populations not sampled, urban/rural and male/female prevalence ratios, using WHO's assumptions from latest global and regional-level estimations. Uncertainty intervals were obtained by bootstrap resampling. Results Estimated syphilis prevalence (in men and women) declined from 1.9% (95% CI 1.1% to 3.4%) in 2000 to 1.5% (1.3% to 1.8%) in 2016 in Zimbabwe, and from 1.5% (0.76% to 1.9%) to 0.55% (0.30% to 0.93%) in Morocco. At these time points, gonorrhoea estimates for women aged 15–49 years were 2.5% (95% CI 1.1% to 4.6%) and 3.8% (1.8% to 6.7%) in Zimbabwe; and 0.6% (0.3% to 1.1%) and 0.36% (0.1% to 1.0%) in Morocco, with male gonorrhoea prevalences 14% lower than female prevalence. Conclusions This epidemiological framework facilitates data review, validation and strategic analysis, prioritisation of data collection needs and surveillance strengthening by national experts. We estimated ongoing syphilis declines in both Zimbabwe and Morocco. For gonorrhoea, time trends were less certain, lacking recent population-based surveys.
Collapse
Affiliation(s)
| | - Guy Mahiané
- Avenir Health, Glastonbury, Connecticut, USA
| | | | | | - Laith Abu-Raddad
- Weill Cornell Medical College-Qatar, Cornell University, Doha, Qatar
| | - Francis Ndowa
- Skin & Genito-Urinary Medicine Clinic, Harare, Zimbabwe
| | - Amina El-Kettani
- Ministry of Health, Direction de l'Epidémiologie & Service de Maladies Sexuellement Transmissibles, Rabat, Morocco
| | | | | | | | | | | | - Teodora Wi
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| |
Collapse
|
30
|
Yanagihara TK, Grinband J, Rowley J, Cauley KA, Lee A, Garrett M, Afghan M, Chu A, Wang TJC. A Simple Automated Method for Detecting Recurrence in High-Grade Glioma. AJNR Am J Neuroradiol 2016; 37:2019-2025. [PMID: 27418469 DOI: 10.3174/ajnr.a4873] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2016] [Accepted: 05/16/2016] [Indexed: 02/04/2023]
Abstract
Our aim was to develop an automated multiparametric MR imaging analysis of routinely acquired imaging sequences to identify areas of focally recurrent high-grade glioma. Data from 141 patients treated with radiation therapy with a diagnosis of high-grade glioma were reviewed. Strict inclusion/exclusion criteria identified a homogeneous cohort of 12 patients with a nodular recurrence of high-grade glioma that was amenable to focal re-irradiation (cohort 1). T1WI, FLAIR, and DWI data were used to create subtraction maps across time points. Linear regression was performed to identify the pattern of change in these 3 imaging sequences that best correlated with recurrence. The ability of these parameters to guide treatment decisions in individual patients was assessed in a separate cohort of 4 patients who were treated with radiosurgery for recurrent high-grade glioma (cohort 2). A leave-one-out analysis of cohort 1 revealed that automated subtraction maps consistently predicted the radiologist-identified area of recurrence (median area under the receiver operating characteristic curve = 0.91). The regression model was tested in preradiosurgery MRI in cohort 2 and identified 8 recurrent lesions. Six lesions were treated with radiosurgery and were controlled on follow-up imaging, but the remaining 2 lesions were not treated and progressed, consistent with the predictions of the model. Multiparametric subtraction maps can predict areas of nodular progression in patients with previously treated high-grade gliomas. This automated method based on routine imaging sequences is a valuable tool to be prospectively validated in subsequent studies of treatment planning and posttreatment surveillance.
Collapse
Affiliation(s)
- T K Yanagihara
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
| | | | - J Rowley
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
| | - K A Cauley
- Radiology (J.G., K.A.C.)
- Division of Neuroradiology (K.A.C.), Geisinger Medical Center, Danville, Pennsylvania
| | - A Lee
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
| | - M Garrett
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
| | - M Afghan
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
- Department of Radiation Oncology (M.A.), Albany Medical Center, Albany, New York
| | - A Chu
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
| | - T J C Wang
- From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.)
- Herbert Irving Comprehensive Cancer Center (T.J.C.W.), Columbia University Medical Center, New York, New York
| |
Collapse
|
31
|
Yanagihara T, Grinband J, Rowley J, Lee A, Cauley K, Chu A, Garrett M, Saadatmand H, Sheth S, Sisti M, Bruce J, McKhann G, Iwamoto F, Lassman A, Cheng S, Wang T. Multiparametric Subtraction Maps Guide Treatment Decisions in Focally Recurrent High-Grade Glioma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
32
|
Fatzinger McShane P, Gathogo A, Rowley J. Promoting Professionalism through Involvement in Professional Meetings with an Informatics Twist. J Acad Nutr Diet 2016. [DOI: 10.1016/j.jand.2016.06.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One 2015; 10:e0143304. [PMID: 26646541 PMCID: PMC4672879 DOI: 10.1371/journal.pone.0143304] [Citation(s) in RCA: 991] [Impact Index Per Article: 110.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2015] [Accepted: 11/02/2015] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis. METHODS AND FINDINGS WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2% (95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8% (0.6-1.0%), trichomoniasis 5.0% (4.0-6.4%), and syphilis 0.5% (0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6% (0.4-0.9%), trichomoniasis 0.6% (0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex. CONCLUSIONS Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level.
Collapse
Affiliation(s)
- Lori Newman
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
- * E-mail:
| | - Jane Rowley
- Consultant to Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | - Stephen Vander Hoorn
- Consultant to Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
- Statistical Consulting Centre, University of Melbourne, Melbourne, Australia
| | - Nalinka Saman Wijesooriya
- Consultant to Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | - Magnus Unemo
- WHO Collaborating Centre for Gonorrhoea and other STIs, Department of Laboratory Medicine, Örebro University Hospital and Örebro University, Örebro, Sweden
| | - Nicola Low
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
| | - Gretchen Stevens
- Department of Health Statistics and Information Systems, World Health Organization, Geneva, Switzerland
| | - Sami Gottlieb
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | - James Kiarie
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| | - Marleen Temmerman
- Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
| |
Collapse
|
34
|
Ambler G, Toon D, Rowley J, Forouhi P. Tumour size predicts seroma severity following breast surgery. Eur J Surg Oncol 2010. [DOI: 10.1016/j.ejso.2010.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
35
|
Abstract
We measured maximum temperature rises on the side of the face after 6 min of continuous mobile phone operation using two models of AMPS analog phones operating in the 835 MHz band and three early model GSM digital phones operating in the 900 MHz band. For the GSM phones the highest recorded temperature rise difference was 2.3 degrees C and for the AMPS phones it was 4.5 degrees C, both at locations on the cheek. The higher differential temperature rise between AMPS and GSM may reflect the higher maximum average operating power of AMPS (600 mW) versus GSM900 (250 mW). Additionally, we compared temperature changes at a consistent location on the cheek for an AMPS phone that was inoperative (-0.7 degrees C), transmitting at full power (+2.6 degrees C) and in stand-by mode (+2.0 degrees C). Our results suggest that direct RF heating of the skin only contributes a small part of the temperature rise and that most is due to heat conduction from the handset.
Collapse
Affiliation(s)
- V Anderson
- THL Australia, St. Leonards, NSW, Australia.
| | | |
Collapse
|
36
|
Abstract
UNLABELLED A new photocatalytic oxidation air filter (PCO unit) has been designed for aircraft cabin applications. The PCO unit is designed as a regenerable VOC removal system in order to improve the quality of the recirculated air entering the aircraft cabin. The PCO was designed to be a modular unit, with four UV lamps sandwiched between two interchangeable titanium dioxide coated panels. Performances of the PCO unit has been measured in a single pass mode test rig in order to show the ability of the unit to decrease the amount of VOCs (toluene, ethanol, and acetone) entering it (VOCs are fed separately), and in a multipass mode test rig in order to measure the ability of the unit to clean the air of an experimental room polluted with the same VOCs (fed separately). Triangular cell panels have been chosen instead of the wire mesh panels because they have higher efficiency. The efficiency of the PCO unit depends on the type of VOCs that challenges it, toluene being the most difficult one to oxidise. The efficiency of the PCO unit decreases when the air flow rate increases. The multipass mode test results show that the VOCs are oxidized but additional testing time would be necessary in order to show if they can be fully oxidized. The intermediate reaction products are mainly acetaldehyde and formaldehyde whose amount depends on the challenge VOC. The intermediate reaction products are also oxidized and additional testing time would be necessary in order to show if they can be fully oxidized. The development of this new photocatalytic air filter is still going on. PRACTICAL IMPLICATIONS The VOC/odor removing adsorbers are available for only a small proportion of aircraft currently in service. The photocatalytic oxidation (PCO) technique has appeared to be a promising solution to odors problems met in aircraft. This article reports the test results of a new photocatalytic oxidation air filter (PCO unit) designed for aircraft cabin applications. The overall efficiency of the PCO unit is function of the compound (toluene, ethanol, and acetone) that challenges the unit and toluene appears to be the most difficult compound to oxidize. Test results have shown the influence of the design of the PCO unit, the air flow rate and the type of UV on the efficiency of the PCO unit. The results obtained in this study represent a first attempt on the way to design a filter for VOC removal in cabin aircraft applications. The PCO technique used by the tested prototype unit is able to partially oxidized the challenge VOCs but one has to be aware that some harmful intermediate reaction products (mainly formaldehyde and acetaldehyde) are produced during the oxidation process before being partially oxidized too.
Collapse
Affiliation(s)
- A Ginestet
- CETIAT, Centre Technique des Industries Aérauliques et Thermiques, Domaine Scientifique de la Doua, 25 avenue des Arts, Villeurbanne Cedex, France.
| | | | | | | | | |
Collapse
|
37
|
Xu R, DeLuca K, Porter W, Garretson L, Rowley J, Liebmann-Vinson A. In vitro umbilical cord blood expansion resulting in unique CD34Bright cell population that engrafts in NOD/SCID mice. Biol Blood Marrow Transplant 2005. [DOI: 10.1016/j.bbmt.2004.12.206] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Jain S, Weinbren M, Rowley J, Bradley A. Arterial blood gas syringe safety device: does it present a greater hazard? J Hosp Infect 2004; 57:264-5. [PMID: 15236858 DOI: 10.1016/j.jhin.2004.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2004] [Indexed: 10/26/2022]
|
39
|
Abstract
The efficacy of current landfill gas and radon mitigation measures for the prevention of ingress of organic vapours was investigated by the study of four houses situated on contaminated land in North West England. The chemical present in the ground of greatest concern for health due to exposure to vapour in the indoor air was hexachlorobutadiene (HCBD) and the concentration of this compound was used to assess the effectiveness of the remedial measures. A two stage remediation was undertaken. For a house with a solid floor the top surface of the floor was sealed and then for the second stage a fan was used to pressurise the soil gas beneath the house. In a house with a suspended timber floor, extra air bricks were installed to increase ventilation of the floor void and then a fan to further increase air exchange in the void. HCBD in air was monitored by both pumped and diffusive sampling methods. Control houses were also monitored that were not subject to remediation. It is concluded that the remedial measures used for radon protection of a suspended floor have the potential to reduce indoor HCBD concentrations by about 80%, at least in downstairs rooms (where initial levels were highest). The two techniques used for properties with solid floors do not appear to be as effective, and no benefit at all was seen without making allowances for changes in concentration that occurred in the control house over the same period. Further work is required to test the efficacy of the techniques over a longer period and under different circumstances of type of contamination and building characteristics.
Collapse
Affiliation(s)
- D Crump
- BRE Environment, BRE, Watford, Herts, WD25 9XX, UK
| | | | | | | |
Collapse
|
40
|
Abstract
Home treatment with antimalarials is a common practice in many countries, and may save lives by ensuring that more malaria cases receive prompt treatment. Through retrospective surveys we found that home treatment of young children with antimalarials was uncommon in rural Gambia. Few families kept medicines in the home in case of illness, 28% kept paracetamol and only 8% kept chloroquine. Less than 10% of cases of childhood 'malaria' had been treated with chloroquine at home, and 69% of those giving home medication did not know the correct dosage for a child. The most common course of treatment was the use of paracetamol and/or tepid sponging to reduce fever, before the child was taken to a government health facility. Treating a child with antimalarials at home was more costly than other forms of treatment. The low cost associated with the use of health services for children and the limited availability of antimalarials outside major towns contribute to the high use of government health services. This shows that that home treatment cannot be assumed to be the predominant mode of malaria treatment throughout Africa, and highlights the need for country-specific policies based on accurate local knowledge of treatment practices in both rural and urban areas.
Collapse
Affiliation(s)
- Siân E Clarke
- Danish Bilharziasis Laboratory, Charlottenlund, Denmark.
| | | | | | | | | |
Collapse
|
41
|
Rowley J. Conference report. A victory for women. People Planet 2002; 3:34-6. [PMID: 12319116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
|
42
|
Rowley J. Investing in people. People Planet 2002; 3:3. [PMID: 12345838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
|
43
|
Rowley J. On course for the 21st century? People Planet 2002; 6:10-1. [PMID: 12321012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
|
44
|
Halberstadt C, Austin C, Rowley J, Culberson C, Loebsack A, Wyatt S, Coleman S, Blacksten L, Burg K, Mooney D, Holder W. A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng 2002; 8:309-19. [PMID: 12031119 DOI: 10.1089/107632702753725067] [Citation(s) in RCA: 124] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Soft tissue reconstruction using tissue-engineered constructs requires the development of materials that are biocompatible and support cell adhesion and growth. The objective of this study was to evaluate the use of macroporous hydrogel fragments that were formed using either unmodified alginate or alginate covalently linked with the fibronectin cell adhesion peptide RGD (alginate-RGD). These materials were injected into the subcutaneous space of adult, domesticated female sheep and harvested for histological comparisons at 1 and 3 months. In addition, the alginate-RGD porous fragments were seeded with autologous sheep preadipocytes isolated from the omentum, and these cell-based constructs were also implanted. The results from this study indicate that both the alginate and alginate-RGD subcutaneous implants supported tissue and vascular ingrowth. Furthermore, at all time points of the experiment, a minimal inflammatory response and capsule formation surrounding the implant were observed. The implanted materials also maintained their sizes over the 3-month study period. In addition, the alginate-RGD fragments supported the adhesion and proliferation of sheep preadipocytes, and adipose tissue was present within the transplant site of these cellular constructs, which was not present within the biomaterial control sites.
Collapse
Affiliation(s)
- C Halberstadt
- General Surgery Research, Carolinas Medical Center, Charlotte, North Carolina 28232-2861, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Loebsack A, Greene K, Wyatt S, Culberson C, Austin C, Beiler R, Roland W, Eiselt P, Rowley J, Burg K, Mooney D, Holder W, Halberstadt C. In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J Biomed Mater Res 2001; 57:575-81. [PMID: 11553888 DOI: 10.1002/1097-4636(20011215)57:4<575::aid-jbm1204>3.0.co;2-9] [Citation(s) in RCA: 76] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Tissue engineered biomaterial constructs are needed for plastic and reconstructive applications. To successfully form a space-filling tissue, the construct should induce a minimal inflammatory response, create minimal or no fibrotic capsule, and establish a vascular bed within the first few days after implantation to ensure survival of the implanted cells. In addition, the biomaterial should support cellular adhesion and induce tissue ingrowth. A macroporous hydrogel bead using sodium alginate covalently coupled with an arginine, glycine, and aspartic acid-containing peptide was created. A 6-month subcutaneous rat model study was performed to determine if the implanted material induced tissue ingrowth throughout the implantation area and maintained a three-dimensional vascular bed. The implanted materials produced a vascular bed, minimal inflammation and capsule formation, and good tissue ingrowth throughout the experiment. The material retained its bulking capacity by demonstration of no significant change of the cross-sectional area as measured from the center of the implants after the 2-week time point. In addition, the granulation tissue formed around the implant was loosely organized, and the surrounding tissue had integrated well with the implant. These results indicate that this material has the desired properties for the development of soft-tissue-engineering constructs.
Collapse
Affiliation(s)
- A Loebsack
- Department of General Surgery, Cannon Research Center, Carolinas Medical Center, Charlotte, North Carolina 28232-2861, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Jawara M, Pinder M, Cham B, Walraven G, Rowley J. Comparison of deltamethrin tablet formulation with liquid deltamethrin and permethrin for bednet treatment in The Gambia. Trop Med Int Health 2001; 6:309-16. [PMID: 11348522 DOI: 10.1046/j.1365-3156.2001.00706.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The study aim was to compare three formulations, tablet deltamethrin, liquid deltamethrin and liquid permethrin, for their impact on vector behaviour and persistence. Product acceptance, perceived side-effects and user's perceptions of effectiveness were also investigated. At the beginning of the 1998 rainy season, 255 nets in a Gambian village were dipped in one of the three insecticides. Chemical residue analysis immediately after dipping showed that the target doses were reached for the liquid insecticides, but tablet deltamethrin deposited significantly less. Insecticide persistence at 5 months, however, was highest for the tablet formulation. Susceptibility tests established that Anophelines in this area were sensitive to both insecticides. All three formulations appeared effective as very few live Anophelines, or other mosquitoes, were caught under the treated nets. This conclusion was supported by the bioassay data with both deltamethrin formulations giving over 90% mortality soon after dipping and at 3 months, and at 5 months 70.8 and 79.6% were obtained for deltametrin liquid and tablet, respectively. Permethrin appeared less effective at all times (72.4, 86.8, 59.0%). There were no serious side-effects reported by the villagers following dipping. All three treatments were perceived as effective by the majority (92%) of users and most (93%) wanted to use the insecticide again. Deltamethrin tablets thus appear as good as permethrin for treating bednets in The Gambia. In addition, a tablet formulation is considerable easier to pack and distribute.
Collapse
Affiliation(s)
- M Jawara
- Medical Research Council Laboratories, Fajara, P.O. Box 273, Banjul, The Gambia.
| | | | | | | | | |
Collapse
|
47
|
Lienhardt C, Rowley J, Manneh K, Lahai G, Needham D, Milligan P, McAdam KP. Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis 2001; 5:233-9. [PMID: 11326822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023] Open
Abstract
SETTING Rural and urban health centres in The Gambia, West Africa. OBJECTIVES To estimate the time delay between onset of symptoms and initiation of treatment and identify the risk factors influencing the delay in patients with tuberculosis (TB). DESIGN Structured interviews with newly diagnosed TB patients aged over 15 years presenting to TB control staff in four health centres. RESULTS A total of 152 TB patients were interviewed. The median delay from onset of symptoms to commencement of treatment was 8.6 weeks (range 5-17). Delay to treatment was independent of sex, but was shorter in young TB patients. The median delay was longer in rural than in urban areas (12 weeks [range 8.5-17] vs. 8 [4-12], P < 0.01) and in those who did not attend school, but this effect disappeared after adjusting for age and area of residence. Patients who reported haemoptysis as one of their initial symptoms had shorter delays to treatment. There was no relation between duration of delay to treatment and cure rate, but longer delay did increase the risk of death. CONCLUSION Starting TB patients on treatment as early as possible plays a major role in reducing disease transmission in the community. Key to this is increasing awareness of the signs and symptoms of TB and ensuring easy access to diagnostic facilities and treatment.
Collapse
Affiliation(s)
- C Lienhardt
- Medical Research Council Laboratories, Fajara, Banjul, The Gambia.
| | | | | | | | | | | | | |
Collapse
|
48
|
Best D, Rawaf S, Rowley J, Floyd K, Manning V, Strang J. Ethnic and gender differences in drinking and smoking among London adolescents. Ethn Health 2001; 6:51-57. [PMID: 11388087 DOI: 10.1080/13557850123660] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
OBJECTIVES The study examines stages of drinking and smoking careers and transitions from initiation to regular use among adolescents, as a function of ethnic status and gender. DESIGN The data were collected using a confidential, self-completion questionnaire assessing onset and frequency of drinking and smoking. The sample consisted of 1777 adolescents, between the ages of 11 and 14, drawn from eight secondary schools in south-west London. RESULTS For both smoking and drinking, white children were more likely to have ever smoked tobacco and drunk alcohol, and were also more likely to progress from initiation to regular use than were either black or Asian children. Asian children reported the latest onset and the lowest prevalence rates for both drinking and smoking. Males reported experimenting with both cigarettes and alcohol at an earlier age than females, although a lower proportion of males report regular and lifetime involvement with both alcohol and tobacco. Furthermore, a significantly higher proportion of females who try smoking go on to do so regularly. DISCUSSION The importance of sociocultural factors in relation to race and gender in predicting onset and escalation of substance use is discussed. The fact that age of onset does not appear to be a significant determinant of transition rate from initiation to regular use is also explored.
Collapse
Affiliation(s)
- D Best
- National Addiction Centre (Maudsley Hospital/Institute of Psychiatry), 4 Windsor Walk, Denmark Hill, London SE5 8AF, UK
| | | | | | | | | | | |
Collapse
|
49
|
Bowman RJ, Sillah A, Van Dehn C, Goode VM, Muqit MM, Muquit M, Johnson GJ, Milligan P, Rowley J, Faal H, Bailey RL. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci 2000; 41:4074-9. [PMID: 11095598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023] Open
Abstract
PURPOSE World Health Organization guidelines for antibiotic treatment of trachoma currently include a 6-week course of tetracycline eye ointment twice daily or a single dose of oral azithromycin. Previous trials have shown similar efficacy of these two alternatives when administration of the ointment was carefully supervised. It is believed, however, that azithromycin may be a more effective treatment in practice, and the purpose of this study was to test that hypothesis. METHODS A masked randomized controlled trial was conducted to compare azithromycin and tetracycline under practical operational conditions-i.e., without supervision of the administration of the ointment. Three hundred fourteen children aged 6 months to 10 years with clinically active trachoma were recruited and individually randomized to receive one of the two treatments. Follow-up visits were conducted at 10 weeks and 6 months. The outcome was resolution of disease (clinical "cure"). RESULTS Children allocated to azithromycin were significantly more likely to have resolved disease than those allocated to tetracycline, both at 10 weeks (68% versus 51%; cure rate ratio, 1.31; 95% confidence interval [CI], 1.08-1.59; P = 0.007) and at 6 months (88% versus 73%; cure rate ratio, 1.19; 95% CI, 1.06-1.34; P = 0.004). Azithromycin was particularly effective for intense inflammation (P = 0.023, Fisher's exact test). CONCLUSIONS Single-dose oral azithromycin was a more effective treatment for active trachoma than tetracycline ointment as applied by caregivers. The high cure rate achieved with tetracycline in this study in the absence of supervision and the significantly higher costs of azithromycin, suggest that in the absence of donation programs, switching routine treatment from tetracycline to azithromycin would not be a good use of resources.
Collapse
Affiliation(s)
- R J Bowman
- International Centre for Eye Health, London, United Kingdom. National Eye Care Program of The Gambia, Banjul. University of Maastricht Medical School, The Netherlands.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Best D, Rawaf S, Rowley J, Floyd K, Manning V, Strang J. Drinking and smoking as concurrent predictors of illicit drug use and positive drug attitudes in adolescents. Drug Alcohol Depend 2000; 60:319-21. [PMID: 11053768 DOI: 10.1016/s0376-8716(00)00113-7] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The study investigates the relationship between smoking and drinking, and the use of illicit drugs in a cohort of London adolescents. A high prevalence of drug experimentation and positive attitudes to illicit drug use were characteristic of those who both drank alcohol and smoked cigarettes on a regular basis. There was then a clear hierarchy in which lower prevalence of use and more negative attitudes marked those who only smoked, then those who only drank, while non-smokers and non-drinkers (the largest group) had lowest lifetime and recent drug use prevalence and the most negative attitudes about drug use.
Collapse
Affiliation(s)
- D Best
- National Addiction Centre, The Maudsley Hospital/Institute of Psychiatry, 4 Windsor Walk, Denmark Hill, London SE5 8AF, UK
| | | | | | | | | | | |
Collapse
|